8 Publications
2004
The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
Gorski, J. C⋅Huang, Shiew-Mei⋅Pinto, Amar⋅Hamman, Mitchell A⋅Hilligoss, Janna K⋅Zaheer, Narjis A⋅Desai, Mehul⋅Miller, Margaret and Hall, Stephen D
Clinical pharmacology and therapeutics. , vol. 75, (no. 1), pp. 89-100, 2004/Jan. | Journal Article
2003
Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
Desai, M.⋅Tanus Dos Santos, José Eduardo⋅Li, L.⋅Gorski, J. C⋅Arefayene, M.⋅Liu, Y.⋅Desta, Zeruesenay and Flockhart, David A
Pharmacogenomics Journal, vol. 3, (no. 2), pp. 105-113, 2003. | Journal Article
 
The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity.
Ward, Bryan A⋅Ward, Bryan⋅Gorski, J. C⋅Gorski, J.⋅Jones, David R⋅Jones, David⋅Hall, Stephen D⋅Hall, Stephen⋅Flockhart, David A⋅Flockhart, David⋅Desta, Zeruesenay and Desta, Zeruesenay
The Journal of pharmacology and experimental therapeutics, vol. 306, (no. 1), pp. 287-300, 2003/Jul. | Journal Article
 
The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
Gorski, J. C⋅Vannaprasaht, Suda⋅Hamman, Mitchell A⋅Ambrosius, Walter T⋅Bruce, Melissa A⋅Haehner-Daniels, Barbara and Hall, Stephen D
Clinical pharmacology and therapeutics. , vol. 74, (no. 3), pp. 275-87, 2003/Sep. | Journal Article
2001
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
Chalasani, N⋅Chalasani, Naga⋅Gorski, J.Christopher⋅Gorski, J. C⋅Patel, Nilesh H⋅Patel, N H⋅Hall, Stephen D⋅Hall, Stephen D⋅Galinsky, Raymond E and Galinsky, Raymond E
Hepatology (Baltimore, Md.), vol. 34, (no. 6), pp. 1103-8, 2001/Dec. | Journal Article
2000
In vivo effects of interleukin-10 on human cytochrome P450 activity.
Gorski, J. C⋅Hall, Stephen D⋅Becker, P⋅Affrime, M B⋅Cutler, D L and Haehner-Daniels, B
Clinical pharmacology and therapeutics, vol. 67, (no. 1), pp. 32-43, 2000/Jan. | Journal Article
1999
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily.
Gorski, J. C⋅Jones, David R⋅Hamman, M A⋅Wrighton, S A and Hall, Stephen D
Xenobiotica; the fate of foreign compounds in biological systems. , vol. 29, (no. 9), pp. 931-44, 1999/Sep. | Journal Article
1997
Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.
Gorski, J. C⋅Jones, David R⋅Wrighton, S A and Hall, Stephen D
Xenobiotica; the fate of foreign compounds in biological systems, vol. 27, (no. 3), pp. 243-56, 1997/Mar. | Journal Article